Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Remoxy NDA Set For Q2 Following Positive Phase III Results

Related Content

King Signs On To Develop Pain Therapeutics’ Abuse-Resistant Oxycodone

Nov 10 2005

Durect Reports Positive Phase IIb Results For Posidur In Post-Op Hernia Pain

Jul 17 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window